Upadacitinib versus Placebo or Adalimumab in Patients with Rheumatoid Arthritis and an Inadequate Response to Methotrexate: Results of a Phase 3, Double-Blind, Randomized Controlled Trial
Arthritis Rheumatol 2019 DOI: 10.1002/art.41032
View and download slide summaries of the latest original articles focusing on therapies in immune-mediated inflammatory diseases including rheumatology, dermatology, and gastroenterology. All materials produced by the team are subsequently reviewed and approved by individual Steering Committee members.
Arthritis Rheumatol 2019 DOI: 10.1002/art.41032
Ann Rheum Dis 2019 DOI: 10.1136/annrheumdis-2019-215764
Arthritis Care and Research 2019 DOI: 10.1002/acr.24010
Ann Rheum Dis. 2019 Jul;78(7):890-898.
EULAR 2019 Abstract LB0003 Presentation
EULAR 2019 Abstract LB0001 Presentation
J Immunol 2019;202:2888–2906. DOI: 10.4049/jimmunol.1800583
Ann Rheum Dis. 2019 Aug;78(8):1048-1054.
Lancet. 2019 Jun 8;393(10188):2303-2311
Rheumatology (Oxford). DOI: 10.1093/rheumatology/kez087